FDA — authorised 14 December 2016
- Marketing authorisation holder: ANACOR PHARMS INC
- Status: approved
🇺🇸 Eucrisa in United States
FDA authorised Eucrisa on 14 December 2016
Marketing authorisations
FDA — authorised 14 December 2016
- Application: NDA207695
- Marketing authorisation holder: ANACOR PHARMS INC
- Local brand name: EUCRISA
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA
- Application: ANDA216242
- Marketing authorisation holder: MACLEODS PHARMS LTD
- Local brand name: CRISABOROLE
- Indication: OINTMENT
- Status: approved
Eucrisa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Eucrisa approved in United States?
Yes. FDA authorised it on 14 December 2016; FDA authorised it on 14 December 2016; FDA has authorised it.
Who is the marketing authorisation holder for Eucrisa in United States?
ANACOR PHARMS INC holds the US marketing authorisation.